These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 13427227)

  • 1. [Inverse effects of hyaluronidase and antihyaluronidase serum on the development of mammary carcinoma in the mouse].
    LACASSAGNE A; LOISELEUR J; RUDALI G
    C R Hebd Seances Acad Sci; 1957 Mar; 244(12):1587-9. PubMed ID: 13427227
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of spreading factors on the development of mouse mammary carcinoma].
    LACASSAGNE A; LOISELEUR J; RUDALI G
    Bull Assoc Fr Etud Cancer; 1957 Dec; 44(4):552-72. PubMed ID: 13523265
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of typological characteristics of the higher nervous activity in the appearance and development of mouse mammary carcinoma].
    MALIUGINA LL; MIRONOVA AI; FEDOROV VK; SHABAD LM
    Biull Eksp Biol Med; 1958 Jun; 45(6):85-9. PubMed ID: 13560552
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of roentgen irradiation on the tumor bed. I. The inhibiting action of local pretransplantation roentgen irradiation (1500 r alpha) on the growth of mouse mammary carcinoma.
    STENSTROM KW; VERMUND H; MOSSER DG; MARVIN JF
    Radiat Res; 1955 Apr; 2(2):180-91. PubMed ID: 14372038
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of roentgen irradiation on the tumor bed. III. The different inhibiting action on the growth of mouse mammary carcinoma resulting from pre- or post-transplantation irradiation.
    VERMUND H; STENSTROM KW; MOSSER DG; LOKEN MK
    Radiat Res; 1958 Jan; 8(1):22-31. PubMed ID: 13506031
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of immune-specific serum on the appearance & development of the ascitic form of Ehrlich mouse carcinoma].
    ROVNOVA ZI
    Vopr Onkol; 1958; 4(4):391-8. PubMed ID: 13604053
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood supply of mouse mammary carcinoma during the developmental process].
    NATADZE TG
    Vopr Onkol; 1958; 4(3):292-5. PubMed ID: 13604035
    [No Abstract]   [Full Text] [Related]  

  • 8. [The problem of appearance of mouse mammary carcinoma].
    RIABININA ZA
    Biull Eksp Biol Med; 1958 Sep; 46(9):105-7. PubMed ID: 13607542
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on metastasis of a transplantable mouse mammary carcinoma after roentgen irradiation.
    VON ESSEN CF; KAPLAN HS
    J Natl Cancer Inst; 1952 Feb; 12(4):883-92. PubMed ID: 14908552
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro study of a mouse mammary carcinoma simulating carsinosarcoma and sarcomatous overgrowth during transplantation.
    RINGSTED J
    Acta Pathol Microbiol Scand; 1957; 40(5):373-83. PubMed ID: 13443966
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyaluronidase and antihyaluronidase of the human serum. I].
    VON BERLEPSCH K
    Biochem Z; 1958; 329(6):542-8. PubMed ID: 13535607
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyaluronidase and antihyaluronidase of human serum. II. Quantitative determination].
    VON BERLEPSCH K
    Biochem Z; 1958; 331(1):49-53. PubMed ID: 13628593
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
    Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP
    Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of living in small and large groups on the development of mammary carcinoma in mice R III].
    ALBERT Z
    Patol Pol; 1956; 7(2):129-39. PubMed ID: 13400519
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum.
    Lukacova S; Khalil AA; Overgaard J; Alsner J; Horsman MR
    Int J Radiat Biol; 2005 Dec; 81(12):937-44. PubMed ID: 16524849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?
    Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R
    Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
    Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
    J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
    Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY
    Cancer Res; 2004 May; 64(10):3525-32. PubMed ID: 15150107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
    Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
    Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir.
    de Moreno de LeBlanc A; Matar C; Farnworth E; Perdigon G
    Cytokine; 2006 Apr; 34(1-2):1-8. PubMed ID: 16697655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.